NAMPT and renal cell carcinoma: This study showed that RCC 786-O cells stimulated by visfatin induced SREBP-1 expression and attenuated the cytotoxicity of sunitinib on RCC cells, while inhibition of visfatin-induced SREBP-1 expression could enhance the effect of sunitinib on 786-O cells.